Design Therapeutics Financial Overview
Design Therapeutics's market cap is currently $554.83M. The company's EPS TTM is $-0.3; its P/E ratio is -8.21; Design Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
